Abstract: . . .  Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21(6):1011-53. [ Medline ] [ Texto completo ] 33. Jurado J, Seip R, Thompson PD. Effectiveness of ezetimibe in clinical practice. Am J Cardiol 2004;93(5):641-3. [ Medline ] 34. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53. [ Medline ] Arriba 2004 fisterra.com Mis Datos | Contacto | Condiciones de uso | Poltica de privacidad http://www.fisterra.com/guias2/ angina .asp (12 de 12) [03/09/2004 20:11:04] </html . . .
. . .  patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999;33(1):273-82 30. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362(9386):782-8. [ Medline ] 31. O'Rourke MF, Nichols WW. Effect of Ramiprilo on cardiovascular events in high-risk patients. N Engl J Med 2000;343(1):64-5; author reply 66. [ Medline ] http://www.fisterra.com/guias2/ angina .asp (11 de 12) [03/09/2004 20:11:04] Page 12 Angina inestable 32. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21(6):1011-53. [ Medline ] [ Texto completo ] 33. Jurado J, Seip R, Thompson PD. Effectiveness of ezetimibe in clinical practice. Am J Cardiol 2004;93(5):641-3. [ Medline ] 34. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53. [ Medline ] Arriba 2004 fisterra.com Mis Datos | Contacto . . .
--3000,2,750,2481,50491